Myeloma: Treating Blood Cancer as a Chronic Disease

Through interactive discussion and attendee feedback on patient cases, this symposium will provide an overview of FDA approved treatments and others being studied in clinical trials for myeloma, including oral therapy, systemic therapy, transplant, CAR T-cell therapy, and bispecific antibodies. The focus will be on the nurse’s role in administering treatment, side-effect management, educating and supporting patients, the role of the interdisciplinary team, and accessing resources for survivorship support. Disparities in diagnosis and treatment of Black Americans, low income, and other underserved populations, as well as issues that impede patients’ access to treatment will also be discussed. Attend this engaging, interactive and fun symposium to learn more!